Home / Import refusals / 1FX-6717023-2/10002/1

FDA Import Refusal 1FX-6717023-2/10002/1 — Zuellig Pharma Corp

Zuellig Pharma Corp — FEI 3009309679

The FDA refused shipment 1FX-6717023-2/10002/1 from Zuellig Pharma Corp (Philippines) on June 17, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 17, 2026
Country
Philippines
Product Category
Drugs and Biologics
Product Code
61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
118,3280

Other import refusals

  • 112-7765708-0/1/1 (Fri Aug 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-8251136-2/3/1 (Wed Aug 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-0229680-5/1/2 (Thu Jan 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-0229680-5/1/4 (Thu Jan 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-0229680-5/1/3 (Thu Jan 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources